Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma [2]

Internal Medicine Journal

Volumn 37, Issue 3, 2007, Pages 205-207

  Cheung, G ^a   Chew, G ^a   Wyndham, R ^a   Peters, M ^a   Riminton, S ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; SCL 70 ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; CASE REPORT; CLINICAL FEATURE; DIFFUSE SCLERODERMA; DISEASE COURSE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PEROXIDASE; SCLERODERMA, DIFFUSE; VASCULITIS;

EID: 33846974666     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01279.x     Document Type: Letter

References (7)

1. Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 2002; 29: 918-23.
2. Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M. ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension. Intern Med 2004; 43: 496-502.
3. Hillis GS, Khan IH, Simpson JG, Rees AJ. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 1997; 30: 279-81.
4. Carvajal I, Bernis C, Sanz P, Garcia A, Garcia-Vadillo A, Traver JA. Antineutrophil cytoplasmic autoantibodies and systemic sclerosis. Nephrol Dial Transplant 1997; 12: 576-7.
5. Villaverde V, Balsa A, Cabezas JA, Fernandez-Prada M, Torre A, Mola EM. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 1999; 38: 190-91.
6. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994; 21: 864-70.
7. Casari S, Haeney M, Farrand S, Herrick A. Antineutrophil cytoplasmic antibodies a 'Red Flag' in patients with systemic sclerosis. J Rheumatol 2002; 29: 2666-7.